Lundbeck pay-for-delay agreement is a by-object infringement, AG says

The European Court of Justice should uphold the European Commission’s €93.8 million fine against pharmaceutical company Lundbeck, an advocate general to the court has recommended.

Get unlimited access to all Global Competition Review content